공시 • Mar 13
Nasdaq to Delist the Ordinary Shares Class A, Unit, Warrant of APx Acquisition Corp I Nasdaq announced that it will delist the ordinary shares Class A, unit, warrant of APx Acquisition Corp. I. APx Acquisition Corp.’s stock was suspended on December 17, 2024 and has not traded on Nasdaq since that time. 공시 • Dec 18
Nasdaq Determines to Delist APx Acquisition Corp. I Securities On December 10, 2024, APX Acquisition Corp. I (the Company") received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (Nasdaq") stating that, pursuant to Nasdaq Listing Rule IM-5101-2 (Rule IM-5101-2"), the staff of Nasdaq (Staff") had determined that (i) the Company's securities will be delisted from Nasdaq, (ii) trading of the Company's Class A common stock, warrants, and units will be suspended at the opening of business on December 17, 2024 and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the SEC"), which will remove the Company's securities from listing and registration on Nasdaq. Under Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement. Since the Company failed to complete its initial business combination by December 6, 2024, the Staff concluded that the Company did not comply with Rule IM-5101-2 and that the Company's securities are now subject to delisting. The Company intends to apply for the listing of its securities on the OTC market after they are delisted from Nasdaq. The delisting from Nasdaq and the commencement of trading on the OTC market does not affect the Company's previously announced business combination with OmnigenicsAI Corp, a Cayman Islands exempted company (Omnigenics"), as both parties continue to work to effectuate the closing of the business combination. Omnigenics will apply for listing of its securities on the Nasdaq Stock Market in connection with the closing of the business combination. The Company will remain a reporting entity under the Securities Exchange Act of 1934, as amended, with respect to continued disclosure of financial and operational information. 공시 • Nov 03
APX Acquisition Announces Nasdaq Delisting Notification for Units As previously announced, on September 4, 2024, APX Acquisition Corp. I (the ‘Company’), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market (‘Nasdaq’) indicating that since the Company's aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set in Listing Rule 5452(b)(C) (the ‘Rule’), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the ‘Notice’). The Company subsequently submitted a plan to regain compliance with the Rule (the ‘Compliance Plan’).On October 29, 2024, the Company received written notice from the Staff (the ‘November Notice’), stating that the Compliance Plan was not accepted as the Company had provided insufficient evidence to demonstrate that it can effect the Compliance Plan by its 36-month expiration date of December 6, 2024, at which time the Company's securities will be delisted from Nasdaq in accordance with IM-5101-2, irrespective of the Company's progress or lack thereof toward regaining compliance with the Rule, and that the Staff had determined to initiate procedures to delist the Company's warrants (and, as a result of the warrants' inclusion therein, the Company's units) from Nasdaq due to the Company's non-compliance. Pursuant to the Notice, unless the Company requests a hearing to appeal this determination by November 5, 2024, the Company's warrants and units will be suspended at the opening of business on November 5, 2024, and a Form 25-NSE will be filed with the SEC, which will remove the Company's warrants and units from listing and registration on Nasdaq (the ‘Warrant/Unit Delisting’). The Company does not intend to request a hearing. The Warrant/Unit Delisting does not affect the listing or trading of the Company's Class A ordinary shares on the Nasdaq Global Market, other than those contained within the units. 공시 • Jun 06
APx Acquisition Corp. I Receives Written Notice from Nasdaq Regarding Non-Compliance with the Nasdaq Listing Rule 5250(c)(1) On May 30, 2024, APx Acquisition Corp. I (the ‘Company’), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market (‘Nasdaq’) indicating that since the Company had not yet filed its Form 10-K for the period ended December 31, 2023 nor had it filed its Form 10-Q for the period ended March 31, 2024, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5250(c)(1) (the ‘Rule’), which requires the Company to timely file all required periodic financial reports with the Securities and Exchange Commission through the EDGAR System (the ‘Notice’). The Notice additionally indicates that the Company, pursuant to the Listing Rules, has 60 calendar days, to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, the Company will have 180 calendar days from the referenced Form 10-K’s due date, or until September 27, 2024, to evidence compliance. If Nasdaq were to reject the Company’s plan, Nasdaq rules permit the Company to appeal the decision to a hearings panel. The Notice serves only as a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Global Market. The Company intends to take action to submit a plan to regain compliance within the 60 calendar days submission period, and, if Nasdaq accepts the plan to regain compliance, to subsequently regain compliance with the Rule within the 180 calendar day compliance period. While the Company is exercising diligent efforts to maintain the listing of its securities on Nasdaq Global Market, there can be no assurance that the Company will be able to regain or maintain compliance with the Rule. In addition, if the Company does not meet the Rule’s requirement by the end of the 180 calendar day compliance period, Nasdaq could provide notice that the Company’s securities will become subject to delisting. In the event the Company receives notice that its securities are being delisted, Nasdaq rules permit the Company to appeal any delisting determination by the Nasdaq staff to a hearings panel. 공시 • Mar 27
OmnigenicsAI Corp entered into a definitive Business Combination Agreement to acquire APx Acquisition Corp. I (NasdaqGM:APXI). OmnigenicsAI Corp entered into a definitive Business Combination Agreement to acquire APx Acquisition Corp. I (NasdaqGM:APXI) on March 26, 2023. Pursuant to the BCA: (i) APx will merge with OmnigenicsAI, with APx being the surviving entity and becoming a wholly owned subsidiary of OmnigenicsAI and (ii) APx’s ordinary shares and warrants will be exchanged for ordinary shares and warrants of OmnigenicsAI. Upon closing, OmnigenicsAI shares and warrants are expected to be publicly listed on Nasdaq under the ticker symbols “OMNI” and “OMNIW”, respectively. The transaction is subject to the approval of APx’s shareholders. The transaction is expected to close mid-year, 2024. Greenberg Traurig, LLP, Maples & Calder (Cayman) LLP and Pérez Alati, Grondona, Benites & Arntsen acted as U.S./U.K., Cayman and Argentine legal counsel, respectively, to APx. EarlyBirdCapital, Inc. acted as M&A advisor to APx. Linklaters LLP, Ogier and Marval, O'Farrell & Mairal acted as U.S., Cayman and Argentine legal counsel, respectively, to OmnigenicsAI. Board Change • Mar 19
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Director Daniel Mudd was the last director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Dec 31
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. 공시 • Dec 29
APX Acquisition Corp. I Receives Nasdaq Notice on Late Filing of Its Form 10-Q APX Acquisition Corp. I announced that it received a deficiency letter (the "Letter") on December 21, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"). The Letter notified the Company that since the Company had not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the "Form 10-Q"), the Company does not comply with Nasdaq's Listing Rule 5250(c)(1) relating to the Company's obligation to file periodic financial reports for continued listing. The Letter further stated that the Company has until February 19, 2024 to submit a plan (the "Plan") to regain compliance with respect to the delinquent reports. The Letter also stated that any staff exemption to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Form 10-Q, or May 12, 2024. If Nasdaq does not accept the Plan, the Company will have the opportunity to appeal that decision to the Nasdaq Hearings Panel. The Company will continue to work with its auditors with the objective of filing the Form 10-Q as soon as practicable and will work diligently to submit the Plan promptly and take the necessary steps to regain compliance as soon as practicable. 공시 • Sep 15
APx Acquisition Corp. I Announces the Resignation of Daniel Braatz as Chairman of the Board On September 8, 2023, effective immediately, the following officers of APx Acquisition Corp. I submitted the resignation of Daniel Braatz as Chairman of the Board. Daniel Braatz will remain as a director on the Board. 공시 • Aug 17
APx Acquisition Corp. I announced delayed 10-Q filing On 08/15/2023, APx Acquisition Corp. I announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • May 17
APx Acquisition Corp. I announced delayed 10-Q filing On 05/16/2023, APx Acquisition Corp. I announced that they will be unable to file their next 10-Q by the deadline required by the SEC.